GGrantIndex
Sort

51,593 grants matching hepatitis

Structural studies with regulatory RNAs

$385,016
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Regulation of Bile Acid Synthesis by Nuclear Receptors

$385,000
John Y. Chiang · Northeast Ohio Medical University · R37 · FY2011 · DK

Nuclear Receptor Signaling Pathways in Atherogenesis

$385,000
Peter J Tontonoz · University Of California Los Angeles · R01 · FY2017 · HL

Post-Translational Regulation of Lipid Metabolism

$385,000
Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2020 · HL

Characterization of Diet1, a hypercholesterolemia resistance gene

$385,000
Karen Reue · University Of California Los Angeles · R01 · FY2011 · HL

Exploring the pathophysiology and treatment of LCHADD retinopathy

$385,000
Melanie B Gillingham · Oregon Health & Science University · R01 · FY2024 · EY

Post-Translational Regulation of Lipid Metabolism

$385,000
Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2021 · HL

Nuclear Receptor Signaling Pathways in Atherogenesis

$385,000
Peter J Tontonoz · University Of California Los Angeles · R01 · FY2018 · HL

Post-Translational Regulation of Lipid Metabolism

$385,000
Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2017 · HL

Transcriptional control of microRNAs in lipid metabolism and atherosclerosis

$385,000
Thomas A Vallim · University Of California Los Angeles · R01 · FY2017 · HL

Novel role of endoplasmic reticulum-associated degradation in iron metabolism

$385,000
Shengyi Sun · Wayne State University · R01 · FY2023 · DK

Transcriptional control of microRNAs in lipid metabolism and atherosclerosis

$385,000
Thomas A Vallim · University Of California Los Angeles · R01 · FY2020 · HL

Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis

$385,000
Maria Serena Longhi · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK

Advancing a novel therapy for preeclampsia

$385,000
Bo Yu · Larix Bioscience, Llc · R43 · FY2022 · HD

IFNalphaBeta-Dependent and-Independent TLR/CD40 Synergy

$385,000
Ross M Kedl · University Of Colorado Denver · R01 · FY2007 · AI

Linked: HIV-Associated Malignancies in Malawi

$385,000
Johnstone Jonny Kumwenda · University Of Malawi · R24 · FY2011 · TW

Orphan Nuclear Receptors in Lipid Metabolism and Inflammation

$385,000
Peter J Tontonoz · University Of California Los Angeles · P01 · FY2019 · HL

TLR-4 IN LIVER IMMUNOREGULATION

$385,000
Ian Nicholas Crispe · University Of Rochester · R56 · FY2007 · AI

Symptom burden in End-Stage Liver Disease patient-caregiver dyads

$385,000
Lissi Hansen · Oregon Health & Science University · R01 · FY2016 · NR

Nuclear Receptor Signaling Pathways in Atherogenesis

$385,000
Peter J Tontonoz · University Of California Los Angeles · R01 · FY2016 · HL

Nuclear Receptor Signaling Pathways in Atherogenesis

$385,000
Peter J Tontonoz · University Of California Los Angeles · R01 · FY2015 · HL

Exploring the pathophysiology and treatment of LCHADD retinopathy

$385,000
Melanie B Gillingham · Oregon Health & Science University · R01 · FY2025 · EY

Novel Post-Transcriptional Regulators of Lipid Metabolism

$385,000
Thomas A Vallim · University Of California Los Angeles · R01 · FY2019 · DK

Endothelial Barrier Function Regulation by VEGF

$385,000
University Of California San Diego · R01 · FY2005 · HL

Transcriptional control of microRNAs in lipid metabolism and atherosclerosis

$385,000
Thomas A Vallim · University Of California Los Angeles · R01 · FY2016 · HL